Drug Trial Radar · NCT07749716
Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata
Last checked: Nov 19, 2026Latest source record: Aug 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
120
Planned (sponsor's estimate)
Start
Aug 18, 2026
Primary completion
Dec 30, 2028
Study completion Dec 30, 2028
Sponsor
- Lead sponsor
- Jiangsu vcare pharmaceutical technology co., LTDIndustry
- Sponsor type
- Industry
- First posted
- Aug 6, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical study designed to evaluate the efficacy and safety of VC005 tablets in subjects with severe alopecia areata (AA).
Conditions
- Alopecia Areata
Interventions
Drug: VC005 tabletsDrug
VC005 repeat administration for 24 weeks
VC005 tabletsDrug
VC005 repeat administration for 24 weeks
VC005 placebo tabletsDrug
VC005 placebo repeat administration for 24 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of subjects with a Severity of Alopecia Tool (SALT) score ≤ 20Time frame: at Week 24 (W24)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Peking University People's Hospital, Beijing, Beijng
Beijing, Beijing Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.